Company profile for Geneos Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Geneos, our passion is to develop personalized therapies to unleash the most powerful force against cancer – your body’s own immune system. Our approach is to target unique neoantigens (abnormal mutations and genomic variations produced by cancer cells) from individual patient tumors to develop novel treatments for cancer. Our technology is designed to identify relevant neoantigen targets and then design, manufacture, a...
At Geneos, our passion is to develop personalized therapies to unleash the most powerful force against cancer – your body’s own immune system. Our approach is to target unique neoantigens (abnormal mutations and genomic variations produced by cancer cells) from individual patient tumors to develop novel treatments for cancer. Our technology is designed to identify relevant neoantigen targets and then design, manufacture, and deliver tumor specific neoantigen-targeted (TSNA-targeted) personalized immunotherapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
660 West Germantown Pike, LL 100 Plymouth Meeting, PA 19462
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250918538806/en/Patients-With-Aggressive-Brain-and-Advanced-Liver-Cancers-Treated-with-Geneos-Personalized-Immunotherapy-for-Cancer-as-Monotherapy-Reach-Five-Years-of-Durable-Recurrence-Free-Survival

BUSINESSWIRE
18 Sep 2025
Geneos cancer vaccine shrinks liver tumors in small trial
Geneos cancer vaccine shrinks liver tumors in small trial

08 Apr 2024

// Julie Steenhuysen REUTERS

https://www.reuters.com/business/healthcare-pharmaceuticals/geneos-cancer-vaccine-shrinks-liver-tumors-small-trial-2024-04-07/

Julie Steenhuysen REUTERS
08 Apr 2024

https://www.prnewswire.com/news-releases/geneos-therapeutics-announces-positive-phase-12-data-for-gt-30-trial-of-personalized-therapeutic-cancer-vaccine-302109588.html

PR NEWSWIRE
07 Apr 2024

https://www.prnewswire.com/news-releases/geneos-therapeutics-closes-its-series-a3-financing-with-investment-of-5-million-301941077.html

PR NEWSWIRE
27 Sep 2023

https://www.prnewswire.com/news-releases/geneos-therapeutics-nominated-for-2023-prix-galien-usa-startup-award-301887990.html

PR NEWSWIRE
28 Jul 2023

https://www.prnewswire.com/news-releases/geneos-therapeutics-secures-5-million-in-series-a3-financing-301795107.html

PR NEWSWIRE
12 Apr 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty